BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Altos Labs Inc.

Headquarters: San Francisco, CA, United States
Year Founded: 2021
Status: Private

BioCentury | Sep 26, 2024
Finance

Eyes on Europe: Asabys’ €180M fund, Genespire’s record series B

BioCentury’s weekly Venture Report also includes Arch’s latest fund, Flagship-backed Mirai, series Bs for Vicebio and 858, and more
BioCentury | Sep 26, 2024
Discovery & Translation

Science Spotlight: Targeted protein relocalization, rejuvenating aged eggs, and more

BioCentury’s roundup of translational innovations
BioCentury | Nov 3, 2023
Discovery & Translation

Dimeric IgA targets intracellular oncogenes; plus taRNAs and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 25, 2023
Finance

Making Mubadala Capital Ventures

How the sovereign’s venture arm has integrated itself into the biotech ecosystem and become a company builder
BioCentury | Jul 21, 2023
Management Tracks

Ann Lee-Karlon named CEO of EpiBiologics

Plus: Haas becomes CEO at LimmaTech, and updates from Sagimet, Agenus, Triumvira and Passage Bio 
BioCentury | Jul 14, 2022
Management Tracks

New CEO at Deerfield-backed Apertura

Plus 10x Genomics hires Wilbur to head commercial, and updates from Immune-Onc, PathAI, Sherlock and more
BioCentury | Jun 30, 2022
Finance

With $3B fund, Arch seeks long-term alignment with LPs, start-ups

Veteran firm aiming to invest biggest-ever Fund XII in companies with high-impact, transformational goals
BioCentury | Jan 20, 2022
Product Development

Barron’s departure leaves unfinished business in GSK’s cancer pipeline

CSO stepping down to join biopharma ‘dream team’ at newly launched Altos
Items per page:
1 - 8 of 8
Help Center
Username
Request Training
Submit Data Correction
Ask a Question